Why Maneki

Built Different.

Maneki has reimagined the relationships between Patients and everyone else to place patients at the heart of the conversation, ensuring they always have an actionable voice through on-chain governance.

Existing Friction vs. Maneki

patient-researcher relations, its near impossible today for a patient to connect directly with the researchers working on their disease	Maneki uses proof-of-condition verifiable credentials to enable privacy preserving relationships between patients and researches
loss of negative research data, this is part of the reason for the current replication crisis in science	Maneki incentivizes the publishing of negative data through disease focused DAOs where patient interests prevail
the undervalued efforts of researchers and patients, who today get almost no ownership	Maneki’s disease focused DAOs take account of everyone's contribution and serves as an IP collective allowing patients and research to take ownership
patients have a hard time understanding the current research for their disease and have little ways of finding laymen term explanations	Maneki’s will allow researchers to annotate their research specifically for patients so they can understand the research
researchers that speak different languages have a very hard time translating research from other countries	Maneki will provide research papers translation in as many languages as possible, using state of the art translation AI
journals reject the vast majority of paper submissions	Maneki will allow anyone to permissionlessly publish anything they want in a x fashion

Maneki’s Features

Patients Researchers

Transparency and trust to verify that funds donated are truly received by researchers for the intended purposes, including ability to enter exclusively verified patient forums

Funding more research and reducing the time to fill out grant application (50% of researchers time) by making it simpler to express ideas with patient communities and donors

Connect directly with researchers and labs working on your disease, ask questions, get informed about clinical trial participation opportunities and share valuable experiential data directly with researchers that will propel research for your disease

Free publishing and reading for all stakeholders, including a re-imagined peer-review system allowing a more vibrant decentralized group of reviewers who now finally receive compensation for their efforts